Dan Stanton

@Dan5tanton

B2B journo focused on biopharma & bioprocessing industry. Information is not knowledge, knowledge is not wisdom. Opinions are all mine and probably not yours

Vrijeme pridruživanja: siječanj 2013.

Tweetovi

Blokirali ste korisnika/cu @Dan5tanton

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Dan5tanton

  1. prije 47 minuta

    Breaking: Catalent to buy Orgenesis' biz Masthercell for $315m - story Insider

    Poništi
  2. prije 4 sata

    Oklahoma has introduced a bill intended to ban the state from prescribing, administering, and making medicinal products and vaccines containing human DNA

    Poništi
  3. 30. sij

    VGXI will make Inovio Pharmaceuticals’ investigational as part of a collaborative effort to halt the progress of the that has recently emerged in China

    Poništi
  4. 30. sij

    Lack of good a factor for in investing $70-90m into internal PA gene therapy plant

    Poništi
  5. 29. sij

    Ori: Partnerships key to bring down cell therapy COGS - UK firm says its automated closed manufacturing platform can reduce autologous COGS by 60-80% and has teamed with

    Poništi
  6. 29. sij
    Poništi
  7. 29. sij
    Poništi
  8. 27. sij

    Top 10 advanced therapy milestones of 2019: Patient access takes center stage

    Poništi
  9. 27. sij

    It's here! Falcon CEO Susan Nichols’ annual roundup of top events within the cell and gene therapy space in 2019, from Contains capacity, and M&A , but takes the top spot

    Poništi
  10. 24. sij

    Discovery Labs' newly formed CDMO in $1.2bn push to deliver capacity to cell & gene space at ex-GSK site in PA - Bioprocess Insider, from

    Poništi
  11. proslijedio/la je Tweet
    23. sij

    FDA rejection letters typically stay private. Correspondence between the agency and shed light on the thinking that led to the rejection and subsequent approval of Duchenne muscular dystrophy drug

    Poništi
  12. 23. sij

    newly formed Center for Breakthrough Medicines from Discovery Labs is building what it claims to be the world’s largest third-party cell and gene production facility at ex-GSK site in King of Prussia, Pennsylvania

    Poništi
  13. 23. sij

    And here is the full story from courtesy of 'CDMO aims ‘big’ in $1.2bn push to deliver capacity to cell & gene space'

    Prikaži ovu nit
    Poništi
  14. 23. sij

    Hey - you changed my flight home without giving a reason. Spoke to your partners (as they awere the US contact on your website) who couldn't explain either but were so helpful and friendly. Maybe you should look to them as a customer service model

    Poništi
  15. proslijedio/la je Tweet
    23. sij

    The Phacilitate Fun Run crew gearing up for a brisk Miami 4k. A great showing, a great cause, and a great conference! Thanks

    Poništi
  16. 23. sij

    Managed 6k!!!

    Prikaži ovu nit
    Poništi
  17. 22. sij

    received a PR claiming creation of world’s largest cell gene . Seemed pie in the sky but talk at by MLP Ventures founder Brian O’Neill behind project was inspirational and 1.6m sqft PA site could turn industry on its head. Ps he got huge cheer from a full room

    Prikaži ovu nit
    Poništi
  18. 22. sij

    FDA cell and gene therapy forecast ‘unlikely’ - the opinion from Phacilitate as number of commercialized therapeutics falls flat after dynamic 2017

    Poništi
  19. 22. sij

    Hey feeling pretty silly that I’ve been using rather than D’oh!

    Poništi
  20. 22. sij

    Mixture of pride of advancement but disappointment in relatively few commercial cell and gene products is the feeling at this year’s in miami. Article to come on

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·